Literature DB >> 5345936

Rubella-neutralizing and haemagglutinin-inhibiting antibodies in children of different ages.

T Brown, M H Hambling, B M Ansari.   

Abstract

Rubella neutralization and haemagglutinin-inhibition tests were used to determine the incidence of rubella antibodies in the sera of 235 children and adolescents aged 1 month to 20 years. The tests showed good agreement in the detection of rubella antibodies resulting from acute infection. Maternal antibodies became undetectable within six months after birth. The proportion of children possessing rubella antibodies was found to be about 23% by the age of 5 years, rising sharply to 80% in the 6-12 years age group and 83% in the 13-20 years age group. Results indicate that the incidence of rubella infection may be higher in females than in males. The correlation between statements concerning a past history of rubella and immune status was poor, particularly in the older age groups. Any policy for vaccination against rubella must take into account the difficulties of identifying nonimmune persons in a large population.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5345936      PMCID: PMC1629690          DOI: 10.1136/bmj.4.5678.263

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  RUBELLA: FREQUENCY OF ANTIBODY AMONG CHILDREN AND ADULTS.

Authors:  J L SEVER; G M SCHIFF; J A BELL; A Z KAPIKIAN; R J HUEBNER; R G TRAUB
Journal:  Pediatrics       Date:  1965-06       Impact factor: 7.124

2.  Rubella in a remote community.

Authors:  F K HILLENBRAND
Journal:  Lancet       Date:  1956-07-14       Impact factor: 79.321

3.  A comparison of the haemagglutination-inhibition test and the neutralisation test for the detection of rubella antibody.

Authors:  A M Field; E M Vandervelde; K M Thompson; D N Hutchinson
Journal:  Lancet       Date:  1967-07-22       Impact factor: 79.321

4.  The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.

Authors:  E H Lennette; N J Schmidt; R L Magoffin
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

5.  Incidence of rubella hemagglutination-inhibiting (HAI) antibody in female subjects in Helsinki.

Authors:  T Vesikari; A Vaheri; M A Kauppinen
Journal:  Ann Med Exp Biol Fenn       Date:  1968

6.  Continuous rabbit kidney cell cultures in the diagnosis of rebella infections.

Authors:  D N Hutchinson; K M Thompson
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1965-11

7.  Rubella. Clinical aspects of prenatal and postnatal infection.

Authors:  J A Dudgeon
Journal:  Public Health       Date:  1967-09       Impact factor: 2.427

8.  [The use of pigeon eruthrocytes in the hemagglutination inhibition test for rubella].

Authors:  J Peetermans; C Huygelen
Journal:  Presse Med       Date:  1967-10-21       Impact factor: 1.228

  8 in total
  3 in total

1.  Fall and rise of immunity to rubella.

Authors:  N D Munro; N J Wild; S Sheppard; R W Smithells; M H Hambling
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Rubella vaccination in the puerperium.

Authors:  J M Beazley; R Hurley; C Middlebrook; M F Rumpus
Journal:  Br J Prev Soc Med       Date:  1971-08

3.  Rubella in Orkney: seroepidemiology and vaccination.

Authors:  M A Moffat; S N Heywood; E Laughton; J J Gould; D S Freestone
Journal:  J Hyg (Lond)       Date:  1977-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.